INTERNATIONAL PATENT: INTELLIA THERAPEUTICS, INC. FILES APPLICATION FOR "POLYPEPTIDES, POLYNUCLEOTIDES, COMPOSITIONS AND METHODS FOR GENOME EDITING INVOLVING CHROMATIN REMODELERS"

GENEVA, May 13 -- INTELLIA THERAPEUTICS, INC. (40 Erie StreetCambridge, Massachusetts 02139) filed a patent application (PCT/US2025/053779) for "POLYPEPTIDES, POLYNUCLEOTIDES, COMPOSITIONS, AND METHODS FOR GENOME EDITING INVOLVING CHROMATIN REMODELERS" on Nov 03, 2025. With publication no. WO/2026/097018, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MULEPATI, Sabin (c/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, Massachusetts 02139), CHOI, Sung Hee (c/o Intellia Therapeutics, Inc.40 Erie StreetCambridge, Massa...